{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T23:26:53Z","timestamp":1777850813017,"version":"3.51.4"},"reference-count":37,"publisher":"SAGE Publications","issue":"12","license":[{"start":{"date-parts":[[2015,1,8]],"date-time":"2015-01-08T00:00:00Z","timestamp":1420675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Feline Medicine and Surgery"],"published-print":{"date-parts":[[2015,12]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Rapidly growing mycobacteria (RGM) infections in cats typically manifest as a panniculitis, requiring long-term antimicrobial therapy for resolution. The search for novel antimicrobial therapies to reduce treatment duration and improve the rate of clinical resolution is imperative. Accordingly, RGM isolates underwent susceptibility testing to some avermectins and other antibacterial drugs currently available.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Five Mycobacterium fortuitum and six Mycobacterium smegmatis isolates obtained from Australian cats underwent susceptibility testing by microbroth dilution to ivermectin, moxidectin, ceftiofur and florfenicol.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>All isolates were resistant to the highest concentrations of ivermectin, moxidectin and ceftiofur tested (1024 \u00b5g\/ml, 256 \u03bcg\/ml and 32 \u03bcg\/ml, respectively). All isolates of M fortuitum were resistant to the highest concentration of florfenicol tested (128 \u00b5g\/ml). The minimum inhibitory concentration range of florfenicol that inhibited growth of M smegmatis isolates was 32\u201364 \u00b5g\/ml.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and relevance<\/jats:title>\n                    <jats:p>All drugs appear to have no efficacy in vitro for the treatment of RGM infections.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/1098612x14565497","type":"journal-article","created":{"date-parts":[[2015,1,9]],"date-time":"2015-01-09T00:42:04Z","timestamp":1420764124000},"page":"1065-1068","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":10,"title":["Susceptibility of rapidly growing mycobacteria isolated from Australian cats to ivermectin, moxidectin, ceftiofur and florfenicol"],"prefix":"10.1177","volume":"17","author":[{"given":"Dennis J","family":"Woerde","sequence":"first","affiliation":[{"name":"Faculty of Veterinary Science, The University of Sydney, Sydney, NSW, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia A","family":"Martin","sequence":"additional","affiliation":[{"name":"Faculty of Veterinary Science, The University of Sydney, Sydney, NSW, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merran","family":"Govendir","sequence":"additional","affiliation":[{"name":"Faculty of Veterinary Science, The University of Sydney, Sydney, NSW, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2015,1,8]]},"reference":[{"key":"bibr1-1098612X14565497","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-5827.2004.tb00193.x"},{"key":"bibr2-1098612X14565497","doi-asserted-by":"publisher","DOI":"10.1053\/jfms.2000.0051"},{"key":"bibr3-1098612X14565497","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-0813.2010.00566.x"},{"key":"bibr4-1098612X14565497","doi-asserted-by":"publisher","DOI":"10.1099\/ijs.0.63094-0"},{"key":"bibr5-1098612X14565497","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.2460\/javma.1992.201.09.1388","volume":"201","author":"Studdert VP","year":"1992","journal-title":"J Am Vet Med Assoc"},{"key":"bibr6-1098612X14565497","doi-asserted-by":"publisher","DOI":"10.1053\/jfms.2001.0189"},{"key":"bibr7-1098612X14565497","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfms.2008.10.008"},{"key":"bibr8-1098612X14565497","doi-asserted-by":"publisher","DOI":"10.1177\/1098612X13489221"},{"key":"bibr9-1098612X14565497","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3164.2012.01104.x"},{"key":"bibr10-1098612X14565497","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2010.06.011"},{"key":"bibr11-1098612X14565497","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01696-12"},{"key":"bibr12-1098612X14565497","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2011.06.001"},{"key":"bibr13-1098612X14565497","unstructured":"Clinical and Laboratory Standards Institute. M24-A2 Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes; approved standard. 2nd ed. Wayne, PA: Clinical and Laboratory Standards Institute, 2011."},{"key":"bibr14-1098612X14565497","first-page":"155","volume-title":"Analytical profiles of drug substances","author":"Fink D","year":"1998"},{"key":"bibr15-1098612X14565497","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2672.92.5s1.7.x"},{"key":"bibr16-1098612X14565497","doi-asserted-by":"publisher","DOI":"10.1002\/bdd.572"},{"key":"bibr17-1098612X14565497","doi-asserted-by":"publisher","DOI":"10.1016\/j.rvsc.2008.08.005"},{"key":"bibr18-1098612X14565497","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-6968.1994.tb07194.x"},{"key":"bibr19-1098612X14565497","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.15.4.716-746.2002"},{"key":"bibr20-1098612X14565497","doi-asserted-by":"publisher","DOI":"10.1179\/joc.2002.14.6.547"},{"key":"bibr21-1098612X14565497","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2008.04.016"},{"key":"bibr22-1098612X14565497","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.38.2.656-661.2000"},{"key":"bibr23-1098612X14565497","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.37.6.1676-1682.1999"},{"key":"bibr24-1098612X14565497","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkt089"},{"key":"bibr25-1098612X14565497","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2885.1999.00200.x"},{"key":"bibr26-1098612X14565497","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.35.9.1760"},{"key":"bibr27-1098612X14565497","first-page":"521","volume":"151","author":"Flores AR","year":"2005","journal-title":"Microbiolog"},{"key":"bibr28-1098612X14565497","doi-asserted-by":"publisher","DOI":"10.1111\/avj.12279"},{"key":"bibr29-1098612X14565497","first-page":"1276","volume":"134","author":"Nash DR","year":"1986","journal-title":"Am Rev Respir Di"},{"key":"bibr30-1098612X14565497","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(97)00286-X"},{"key":"bibr31-1098612X14565497","doi-asserted-by":"publisher","DOI":"10.1016\/B978-070202858-8.50010-5"},{"key":"bibr32-1098612X14565497","first-page":"945","volume-title":"Veterinary pharmacology and therapeutics","author":"Papich MG","year":"2009","edition":"9"},{"key":"bibr33-1098612X14565497","doi-asserted-by":"publisher","DOI":"10.1016\/j.rvsc.2007.04.001"},{"key":"bibr34-1098612X14565497","doi-asserted-by":"publisher","DOI":"10.1080\/00071669708418013"},{"key":"bibr35-1098612X14565497","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2885.2007.00918.x"},{"key":"bibr36-1098612X14565497","doi-asserted-by":"publisher","DOI":"10.1126\/science.8153624"},{"key":"bibr37-1098612X14565497","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200604-571ST"}],"container-title":["Journal of Feline Medicine and Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1098612X14565497","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1098612X14565497","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1098612X14565497","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T22:11:50Z","timestamp":1777500710000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1098612X14565497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,8]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["10.1177\/1098612X14565497"],"URL":"https:\/\/doi.org\/10.1177\/1098612x14565497","relation":{},"ISSN":["1098-612X","1532-2750"],"issn-type":[{"value":"1098-612X","type":"print"},{"value":"1532-2750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,8]]}}}